A Study of MM-111 in Patients With Advanced Her2 Positive Cancers



Status:Archived
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:June 2009
End Date:July 2011

Use our guide to learn which trials are right for you!

A Phase 1-2 and Pharmacologic Study of MM-111 in Patients With Advanced, Refractory Her2 Positive Cancers


This study is an open-label Phase 1-2 trial of MM-111.


Phase 1: Patients with any solid tumor type may be enrolled to evaluate the safety and
tolerability of MM-111.

Phase 2: The Phase 2 portion of the trial is intended to serve as an exploratory study to
assist in the design of future trials.


We found this trial at
2
sites
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
333 Cottman Ave
Philadephia, Pennsylvania 19111
(215) 728-6900
Fox Chase Cancer Center Fox Chase has earned the prestigious designation from the National Cancer...
?
mi
from
Philadephia, PA
Click here to add this to my saved trials